Study of Trastuzumab-emtansine in Patients With HER2-positive Metastatic Colorectal Cancer Progressing After Trastuzumab and Lapatinib.

NCT03418558 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Trastuzumab emtansine

Sponsor

Fondazione del Piemonte per l'Oncologia